Published in Cell Immunol on April 24, 2010
Immunological cell type characterization and Th1-Th17 cytokine production in a mouse model of Gaucher disease. Mol Genet Metab (2012) 0.85
The IL-23/Th17 axis is involved in the adaptive immune response to Bacillus anthracis in humans. Eur J Immunol (2014) 0.81
The intact structural form of LLO in endosomes cannot protect against listeriosis. Int J Biochem Mol Biol (2011) 0.80
IL-6 production by dendritic cells is dispensable for CD8+ memory T-cell generation. Biomed Res Int (2012) 0.80
IL-7 and IL-15 do not synergize during CD8 T cell recall response against an obligate intracellular parasite. Microbes Infect (2012) 0.77
Illuminating the petite picture of T cell memory responses to Listeria monocytogenes. Biomed Res Int (2013) 0.75
Maturation of morphology, phenotype and functions of murine bone marrow-derived dendritic cells (DCs) induced by polysaccharide Kureha (PSK). Hum Vaccin Immunother (2012) 0.75
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol (2005) 30.22
Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature (2003) 22.89
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80
Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity (1998) 17.27
Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol (2003) 15.65
Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity (2007) 12.98
Th17: an effector CD4 T cell lineage with regulatory T cell ties. Immunity (2006) 10.53
Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med (1993) 8.76
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol (2005) 8.27
Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med (1993) 5.71
Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol (2003) 5.54
The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity (2003) 5.11
Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol (2008) 4.88
Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J Clin Invest (2006) 4.77
Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med (2005) 4.45
Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol (2006) 3.78
Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells. J Exp Med (2001) 3.75
Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity (2009) 3.33
Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med (2003) 3.21
Priming of memory but not effector CD8 T cells by a killed bacterial vaccine. Science (2001) 3.00
Generation of CD8 T cell memory is regulated by IL-12. J Immunol (2007) 2.69
Inflaming the CD8+ T cell response. Immunity (2006) 2.44
Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J Immunol (2008) 2.42
Studies with MHC-deficient knock-out mice reveal impact of both MHC I- and MHC II-dependent T cell responses on Listeria monocytogenes infection. J Immunol (1994) 2.39
IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J Immunol (2009) 2.39
Programming, demarcating, and manipulating CD8+ T-cell memory. Immunol Rev (2006) 2.36
Programming for CD8 T cell memory development requires IL-12 or type I IFN. J Immunol (2009) 2.15
Effects of Signal 3 during CD8 T cell priming: Bystander production of IL-12 enhances effector T cell expansion but promotes terminal differentiation. Vaccine (2009) 2.15
The roles of IL-12 in providing a third signal for clonal expansion of naive CD8 T cells. J Immunol (2002) 1.98
Pathogenicity and immunogenicity of Listeria monocytogenes small-plaque mutants defective for intracellular growth and cell-to-cell spread. Infect Immun (1992) 1.77
From interleukin-23 to T-helper 17 cells: human T-helper cell differentiation revisited. Immunol Rev (2008) 1.65
Emergence of the Th17 pathway and its role in host defense. Adv Immunol (2008) 1.65
IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection. J Immunol (2008) 1.64
Manipulating the rate of memory CD8+ T cell generation after acute infection. J Immunol (2007) 1.63
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol (2006) 1.59
Il-12 enhances CD8 T cell homeostatic expansion. J Immunol (2001) 1.51
Antiangiogenic and antitumor activities of IL-27. J Immunol (2006) 1.50
Interleukin-23 and interleukin-27 exert quite different antitumor and vaccine effects on poorly immunogenic melanoma. Cancer Res (2006) 1.49
Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther (2007) 1.48
Distinct in vivo dendritic cell activation by live versus killed Listeria monocytogenes. Eur J Immunol (2005) 1.40
IL-23 is required for protection against systemic infection with Listeria monocytogenes. J Immunol (2009) 1.40
Response to Listeria monocytogenes in mice lacking MHC class Ia molecules. J Immunol (1999) 1.38
Antiproliferative activity of IL-27 on melanoma. J Immunol (2008) 1.33
Deviation from a strong Th1-dominated to a modest Th17-dominated CD4 T cell response in the absence of IL-12p40 and type I IFNs sustains protective CD8 T cells. J Immunol (2008) 1.14
CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells. J Immunol (2009) 1.13
Cytoplasmic entry of Listeria monocytogenes enhances dendritic cell maturation and T cell differentiation and function. J Immunol (2004) 1.10
Antilisterial immunity includes specificity to listeriolysin O (LLO) and non-LLO-derived determinants. Infect Immun (1994) 1.07
IL-12 priming during in vitro antigenic stimulation changes properties of CD8 T cells and increases generation of effector and memory cells. J Immunol (2004) 1.07
A role for IFN-gamma from antigen-specific CD8+ T cells in protective immunity to Listeria monocytogenes. J Immunol (2007) 1.05
Making sense of inflammation, epigenetics, and memory CD8+ T-cell differentiation in the context of infection. Immunol Rev (2006) 1.01
Dendritic cells: a critical player in cancer therapy? J Immunother (2008) 0.99
Tumor-specific cytotoxic T cell generation and dendritic cell function are differentially regulated by interleukin 27 during development of anti-tumor immunity. Int J Cancer (2009) 0.99
Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses. Cancer Res (2005) 0.97
Memory CD4 T cells enhance primary CD8 T-cell responses. Infect Immun (2007) 0.92
Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer. J Immunother Emphasis Tumor Immunol (1993) 0.91
Quantitation of CD8+ T cell expansion, memory, and protective immunity after immunization with peptide-coated dendritic cells. J Immunol (2002) 0.89
Phenotypic changes induced by IL-12 priming regulate effector and memory CD8 T cell differentiation. Int Immunol (2007) 0.81
Defect of CD8+ memory T cells developed in absence of IL-12 priming for secondary expansion. Cell Mol Immunol (2008) 0.78
Interleukin-12: a master regulator. J Exp Med (2007) 0.77
Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat Med (2003) 3.68
Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J Biol Chem (2008) 2.87
Apoptosis regulators Bim and Fas function concurrently to control autoimmunity and CD8+ T cell contraction. Immunity (2008) 2.26
Macrophage ABCA1 reduces MyD88-dependent Toll-like receptor trafficking to lipid rafts by reduction of lipid raft cholesterol. J Lipid Res (2010) 1.82
The requirement of reversible cysteine sulfenic acid formation for T cell activation and function. J Immunol (2007) 1.41
Apolipoprotein A-I and its role in lymphocyte cholesterol homeostasis and autoimmunity. Arterioscler Thromb Vasc Biol (2009) 1.38
Toll-like receptor 2 participates in the response to lung injury in a murine model of pulmonary contusion. Shock (2007) 1.31
Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cells. J Biol Chem (2006) 1.23
The angiotensin II-AT1 receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun (2009) 1.19
Electron transport complex I is required for CD8+ T cell function. J Immunol (2006) 1.17
Toll-like receptor 4-dependent responses to lung injury in a murine model of pulmonary contusion. Shock (2009) 1.17
Apolipoprotein A-I modulates regulatory T cells in autoimmune LDLr-/-, ApoA-I-/- mice. J Biol Chem (2010) 1.17
IL-12 produced by dendritic cells augments CD8+ T cell activation through the production of the chemokines CCL1 and CCL17. J Immunol (2008) 1.11
Cytoplasmic entry of Listeria monocytogenes enhances dendritic cell maturation and T cell differentiation and function. J Immunol (2004) 1.10
Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms. J Virol (2009) 1.07
Antioxidant treatment reduces expansion and contraction of antigen-specific CD8+ T cells during primary but not secondary viral infection. J Virol (2004) 1.05
Differential susceptibility of bone marrow-derived dendritic cells and macrophages to productive infection with Listeria monocytogenes. Cell Microbiol (2007) 1.00
Matrix protein mutant of vesicular stomatitis virus stimulates maturation of myeloid dendritic cells. J Virol (2006) 0.98
Dynamics of dendritic cell maturation are identified through a novel filtering strategy applied to biological time-course microarray replicates. BMC Immunol (2010) 0.94
Enhanced antigen processing of flagellin fusion proteins promotes the antigen-specific CD8+ T cell response independently of TLR5 and MyD88. J Immunol (2011) 0.93
Type I interferon signaling regulates the composition of inflammatory infiltrates upon infection with Listeria monocytogenes. Cell Immunol (2011) 0.92
Mechanism of neutrophil recruitment to the lung after pulmonary contusion. Shock (2011) 0.92
Increased CD8+ T-cell function following castration and immunization is countered by parallel expansion of regulatory T cells. Cancer Res (2012) 0.91
Myeloid cell-specific ABCA1 deletion protects mice from bacterial infection. Circ Res (2012) 0.88
Apoptosis induction and interferon signaling but not IFN-beta promoter induction by an SV5 P/V mutant are rescued by coinfection with wild-type SV5. Virology (2003) 0.88
Differential regulation of primary and memory CD8 T cell immune responses by diacylglycerol kinases. J Immunol (2012) 0.88
Dendritic cells inhibit the progression of Listeria monocytogenes intracellular infection by retaining bacteria in major histocompatibility complex class II-rich phagosomes and by limiting cytosolic growth. Infect Immun (2010) 0.87
The reversible formation of cysteine sulfenic acid promotes B-cell activation and proliferation. Eur J Immunol (2012) 0.87
Regulation of maturation and activating potential in CD8+ versus CD8- dendritic cells following in vivo infection with vaccinia virus. Virology (2008) 0.85
Efficacy of vaccination strategies against intranasal challenge with Brucella abortus in BALB/c mice. Vaccine (2011) 0.84
Changes in functional but not structural avidity during differentiation of CD8+ effector cells in vivo after virus infection. J Immunol (2012) 0.83
Live Brucella abortus rough vaccine strain RB51 stimulates enhanced innate immune response in vitro compared to rough vaccine strain RB51SOD and virulent smooth strain 2308 in murine bone marrow-derived dendritic cells. Vet Microbiol (2010) 0.81
Role of TLRs in Brucella mediated murine DC activation in vitro and clearance of pulmonary infection in vivo. Vaccine (2012) 0.80
Protection to respiratory challenge of Brucella abortus strain 2308 in the lung. Vaccine (2013) 0.79
Antioxidant treatment regulates the humoral immune response during acute viral infection. J Virol (2012) 0.79
Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol (2012) 0.79
Increased cell surface free thiols identify effector CD8+ T cells undergoing T cell receptor stimulation. PLoS One (2013) 0.79
Defects in apoptosis increase memory CD8+ T cells following infection of Bim-/-Faslpr/lpr mice. Cell Immunol (2011) 0.78
Heat-killed and γ-irradiated Brucella strain RB51 stimulates enhanced dendritic cell activation, but not function compared with the virulent smooth strain 2308. FEMS Immunol Med Microbiol (2010) 0.78
The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth. Virology (2008) 0.77
Ability of Brucella abortus rough vaccine strains to elicit DC and innate immunity in lung using a murine respiratory model. Vaccine (2010) 0.76
Peroxiredoxin II regulates effector and secondary memory CD8+ T cell responses. J Virol (2012) 0.76
Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin. J Virol (2013) 0.76